Greylin Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$16.7M Buy
809,119
+15,268
+2% +$303K 2.8% 6
2024
Q1
$14.9M Sell
793,851
-9,246
-1% -$159K 2.39% 6
2023
Q4
$11.6M Buy
803,097
+43,706
+6% +$595K 2% 7
2023
Q3
$13.2M Buy
759,391
+56,995
+8% +$1.19M 2.37% 6
2023
Q2
$14.6M Buy
702,396
+125,823
+22% +$2.73M 2.64% 6
2023
Q1
$13.6M Buy
576,573
+8,724
+2% +$234K 2.47% 7
2022
Q4
$15.9M Buy
567,849
+180,329
+47% +$4.61M 2.92% 6
2022
Q3
$9.07M Buy
387,520
+70,396
+22% +$2.13M 1.89% 13
2022
Q2
$10.7M Buy
+317,124
New +$11.1M 2.07% 12
2022
Q1
Sell
-328,167
Closed -$9.99M 90
2021
Q4
$9.99M Buy
328,167
+677
+0.2% +$22.1K 1.88% 11
2021
Q3
$10.7M Buy
327,490
+89,265
+37% +$2.86M 2.2% 10
2021
Q2
$7.21M Buy
+238,225
New +$7.84M 1.4% 13

Other funds holding OGN

Greylin Investment Management's OGN Position: Q2 2024 in Review

Greylin Investment Management increased its Organon & Co (OGN) stake by 1.9% in Q2 2024, buying an estimated $303K and bringing the position to 809,119 shares worth $16.7M. The position accounts for 2.8% of the portfolio, ranked #6.

Greylin Investment Management first reported a position in OGN in Q2 2021 and has held it in 12 quarters since. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Greylin Investment Management held 809,119 shares of Organon & Co worth $16.7M as of Q2 2024.
  • Greylin Investment Management bought 15,268 Organon & Co shares in Q2 2024, an estimated $303K.
  • Organon & Co made up 2.8% of Greylin Investment Management's portfolio in Q2 2024, its #6 holding.
  • Greylin Investment Management first reported a position in Organon & Co in Q2 2021 and has held it in 12 quarters since.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.